Human leukocyte antigens I and II haplotypes associated with human papillomavirus 16-positive invasive cervical cancer in Mexican women

International Journal of Gynecological Cancer

Volumn 19, Issue 6, 2009, Pages 1099-1106

  Hernández Hernández, Dulce M ^a   Cerda Flores, Ricardo M ^b   Juárez Cedillo, Teresa ^a   Granados Arriola, Julio ^c,g   Vargas Alarcón, Gilberto ^d   Apresa García, Teresa ^a   Alvarado Cabrero, Isabel ^a   García Carrancá, Alejandro ^e,f   Salcedo Vargas, Mauricio ^a   Mohar Betancourt, Alejandro ^e,f  

^a Instituto Mexicano del Seguro Social   (United States)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c Department of Immunology and Rheumatology   (United States)

^d Instituto Nacional de Cardiologia Ignacio Chavez   (United States)

^e UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^f Instituto Nacional de Cancerología   (United States)

^g Hospital de Oncología   (United States)

Author keywords

Cervical cancer; Human leukocyte antigen; Human papillomavirus

Indexed keywords

HLA A2 ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DQB1 ANTIGEN; HLA DR4 ANTIGEN; OLIGONUCLEOTIDE;

ADULT; AGED; ALLELE; ARTICLE; BLOOD CELL COUNT; CANCER INVASION; COMPUTER PROGRAM; CONTROL GROUP; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HISPANIC; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; POPULATION; PRIORITY JOURNAL; RISK; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; VIRUS INFECTION;

ADULT; AGED; CARCINOMA; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMAN PAPILLOMAVIRUS 16; HUMANS; MEXICO; MIDDLE AGED; NEOPLASM INVASIVENESS; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; UTERINE CERVICAL NEOPLASMS;

EID: 70349310090     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181a83cf4     Document Type: Article

References (42)

1. Bor-Ching S, Wen-Chun C, Ho-Hsiung L, et al. Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia. J Obstet Gynaecol Res. 2007;33: 103-113.
2. O'Brien PM, Campo MS. Papillomaviruses: a correlation between immune evasion and oncogenicity? Trends Microbiol. 2003;11: 300-305.
3. Lajous M, Müeller N, Cruz-Valdéz A, et al. Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men. Cancer Epidemiol Biomarkers Prev. 2005;14: 1710-1716.
4. Lazcano-Ponce E, Herrero R, Muñoz N, et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer. 2001;91:412-420.
5. Khan MA. Update on spondyloarthropathies. Ann Intern Med. 2002;136:896-907.
6. Minton EJ, Smillie D, Neal K, the Trent Hepatitis C Virus Study Group. Association between MHC class II alleles and clearance of circulating hepatitis C virus. J Infect Dis. 1998;178:39-44.
7. Apple RJ, Becker TM, Wheeler CM, et al. Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma. J Natl Cancer Inst. 1995;87:427-436.
8. Brown MR, Noffsinger A, First MR, et al. HPV subtype analysis in lower genital tract neoplasms of female renal transplant recipients. Gynecol Oncol. 2000;79:220-224.
9. Jay N, Moscicki AB. Human papillomavirus infections in women with HIV disease: prevalence, risk, and management. AIDS Read. 2000;10:659-668.
10. Tindle RW. Immune evasion in human papillomavirus associated cervical cancer. Nat Rev Cancer. 2002;2:59-65.
11. Dell G, Gaston K. Human papillomaviruses and their role in cervical cancer. Cell Mol Life Sci. 2001;58:1923-1942.
12. Hildesheim A, Schiffman M, Scott DR, et al. Human leukocyte antigen class I/II alleles and development of HPV-related cervical neoplasia: results from a case-control study conducted in the United States. Cancer Epidemiol Biomarkers Prev. 1998;7:1035-1041.
13. Chan PK, Cheung JL, Cheung TH, et al. HLA-B alleles, high-risk HPV infection and risk for cervical neoplasia in southern Chinese women. Int J Cancer. 2006;118:1430-1435.
14. Chan PK, Cheung TH, Lin CK, et al. Association between HLA-DRB1 polymorphism, high-risk HPV infection and cervical neoplasia in southern Chinese. J Med Virol. 2007;79:970-976.
15. Yang YC, Chang TY, Lee YJ, et al. HLA-DRB1 alleles and cervical squamous cell carcinoma: experimental study and meta-analysis. Hum Immunol. 2006;67:331-340.
16. Castro FA, Haimila K, Pasanen K, et al. Geographic distribution of cervical cancer-associated human leukocyte antigens and cervical cancer incidence in Finland. Int J STD AIDS. 2007;18:672-679.
17. Helland A, Borresen AL, Kristensen G, et al. DQA1 and DQB1 genes in patients with squamous cell carcinoma of the cervix: relationship to human papillomavirus infection and prognosis. Cancer Epidemiol Biomarkers Prev. 1994;3:479-486.
18. Cuzick J, Terry G, Ho L, et al. Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women. Br J Cancer. 2000;82:1348-1352.
19. Wank R, Meulen J, Luande J, et al. Cervical intraepithelial neoplasia, cervical carcinoma, and risk for patients with HLA-DQB1*0602, *0301, *0303 alleles. Lancet. 1993;341:1215.
20. Registro Histopatológico de Neoplasias en México. Dirección General de Epidemiología. Secretaría de Salud. Available at: http://www.dgepi.salud.gob.mx/diveent/RHNM.htm. 2002. Accessed March 17, 2008.
21. Clavel C, Masure M, Bory JP, et al. Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high grade cervical lesions: a preliminary study on 1518 women. British Journal of Cancer. 1999;80:1306-1311.
22. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol. 1995;12:921-927.
23. Tevfik D. Statistical Analysis in HLA and Disease Association Studies. Available at: http://www.dorak.info/hla/stat.html. 2005. Accessed January 23, 2008.
24. Sham PC. Statistics in Human Genetics (Arnold Applications of Statistics Series). 1st ed. London, UK: A Hodder Arnold Publication; 1998.
25. Beskow A, Josefsson A, Gyllensten U. HLA class II alleles associated with infection by HPV 16 in cervical cancer in situ. Int J Cancer. 2001;93:817-822.
26. Cruz E, Vieira J, Gonçalves R, et al. Involvement of the major histocompatibility complex region in the genetic regulation of circulating CD8+ T-cell numbers in humans. Tissue Antigens. 2004;64:25-34.
27. Chan DP, Cheung TH, Tam AO, et al. Risk association between human leukocyte antigen-A allele and high-risk human papillomavirus infection for cervical neoplasia in Chinese women. J Infect Dis. 2005;192:1749-1756.
28. Schiff MA, Apple RJ, Lin P, et al. HLA alleles and risk of cervical intraepithelial neoplasia among southwestern American Indian women. Hum Immunol. 2005;66:1050-1056.
29. Lin P, Koutsky LA, Critchlow CW, et al. HLA class II DR-DQ and increased risk of cervical cancer among Senegalese women. Cancer Epidemiol Biomarkers Prev. 2001;10:1037-1045.
30. Madeleine MM, Brumback B, Cushing-Haugen KL, et al. Human leukocyte antigen class II and cervical cancer risk: a population-based study. J Infect Dis. 2002;186:1565-1574.
31. Odunsi K, Terry G, Ho L, et al. Association between HLA DQB1*03 and cervical intraepithelial neoplasia. Mol Med. 1995;1: 161-171.
32. Engelmark M, Beskow A, Magnusson J, et al. Affected sib-pair analysis of the contribution of HLA class I and class II loci to development of cervical cancer. Hum Mol Genet. 2004;13:1951-1958.
33. Wu Y, Liu B, Lin W, et al. Human leukocyte antigen class II alleles and risk of cervical cancer in China. Hum Immunol. 2007;68:192-200.
34. Wang SS, Wheeler CM, Hildesheim A, et al. Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica. J Infect Dis. 2001;184:1310-1314.
35. Sun CA, Liu JF, Wu DM, et al. Viral load of high-risk papillomavirus in cervical squamous intraepithelial lesions. Int J Gynecol Obstet. 2002; 76:41-47.
36. Hernández HDM, Ornelas BL, Guido JMC, et al. Association between high-risk human papillomavirus DNA load and precursor lesions of cervical cancer in Mexican women. Gynecol Oncol. 2003;90:310-317.
37. Fontaine J, Gravitt P, Lee-Min D, et al. The Canadian Women's HIV Study Group. High level of correlation of human papillomavirus-16 DNA viral load estimates generated by three real-time PCR assays applied on genital specimens. Cancer Epidemiol Biomarkers Prev. 2005;14:2200-2207.
38. Mori M, Beatty PG, Graves M, et al. HLA gene and haplotypes frequencies in the North American population: the national marrow donor program donor registry 2000. Available at: http://www.ashi-hla.org/publicationfiles/archives/ prepr/motomi.htm. Accessed March 26, 2008.
39. Berumen J, Ordóñez RM, Lazcano E, et al. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst. 2001;93:1325-1330.
40. Yamada T, Manos MM, Peto J, et al. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol. 1997;71:2463-2472.
41. Ellis JRM, Keating PJ, Baird J, et al. The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat Med. 1995;1:464-470.
42. Chan PK, Cheung JL, Cheung TH, et al. HLA-DQB1 polymorphisms and risk for cervical cancer: a case-control study in a southern Chinese population. Gynecol Oncol. 2007;105:736-741.